IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
Cymbalta
From:
Sylvia Caras <[log in to unmask]>
Reply To:
[log in to unmask]
Date:
Mon, 15 Dec 2008 12:36:20 -0800
Content-Type:
text/plain
Parts/Attachments:
text/plain (12 lines) 
 From PR Newswire - Dec 10, 2008
INDIANAPOLIS, December 10, 2008 /PRNewswire-FirstCall/ -- New data 
suggest that Cymbalta (duloxetine HCl) 60 mg to 120 mg once daily 
delayed the onset of a new episode of depression in patients who had 
previously responded to the medication and who had recurrent 
depressive disorder, defined in the study as those patients who 
experienced at least three depressive episodes in the previous five 
years, compared with placebo (p < .001).


"People Who experience mood swings, fear, voices and visions"

ATOM RSS1 RSS2